Ardian (formerly AXA Private Equity) is teaming up with Laboratoires Anios chief executive Bertrand Letartre and deputy chief executive Thierry Letartre to acquire a majority stake in the business from Air Liquide.
Laboratoires Anios is one of the European leaders in disinfection solutions for hospitals and clinics. The transaction reflects Ardian’s willingness to support Bertrand and Thierry Letartre in their growth strategy for the business.
The proposed transaction remains subject to the signing of a definitive agreement and approvals by the French antitrust authorities and the works council bodies of Laboratoires Anios.
Based in the outskirts of Lille, France, Laboratoires Anios was founded by Fernand Collet-Delaval in 1898 and is now managed by his descendants, Bertrand and Thierry Letartre. Laboratoires Anios has a presence in more than 80 countries. As well as its primary focus on the healthcare sector, Laboratoires Anios also operates in the food-processing, cosmetics, and pharmaceutics industries, as well as working with businesses involved in accommodation and catering.
Laboratoires Anios, which launches more than 30 new products every year, employs around 450 people worldwide, of which 350 are based in France. The company’s two main production sites are located in Sainghin-en-Mélantois and in Hellemmes, France.
Ardian will support Laboratoires Anios accelerate its international footprint, with 30 per cent of its turnover already being generated outside France. International build up acquisitions will form the heart of the company’s growth strategy, which will be supported by ongoing investment, notably in R&D.
Bertrand Letartre says: “We are pleased to welcome Ardian as a partner in our business. The transaction will give us a sustainable shareholding structure for the group and the platform to accelerate the implementation of our strategy.”
Thierry Letartre adds: “We decided to partner with Ardian as we have been impressed by the industry knowledge and know-how of the team. We also share a common set of values.”
Philippe Poletti, head of mid market enterprise capital at Ardian, says: “This transaction fits perfectly with Ardian’s investment strategy. Laboratoires Anios have all the key indicators of future success – they are a leader in a growing niche market, and has real potential for considerable international growth. We will provide Laboratoires Anios with all necessary resources to support the company’s ambitious development plans.”
